Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
(NASDAQ: BMEA) Delayed: 1.32 -0.17 (11.41%)
Previous Close $1.49    52 Week High $ 
Open $1.49    52 Week Low $ 
Day High $1.49    P/E N/A 
Day Low $1.30    EPS $ 
Volume 3,080,856